Literature DB >> 14695091

Comparison of artificial membrane feeding with direct skin feeding to estimate the infectiousness of Plasmodium vivax gametocyte carriers to mosquitoes.

Jetsumon Sattabongkot1, Nongnuj Maneechai, Vichit Phunkitchar, Nantana Eikarat, Benjawan Khuntirat, Jeeraphat Sirichaisinthop, Robert Burge, Russell E Coleman.   

Abstract

The efficacy of a membrane-feeding apparatus as a means of infecting Anopheles dirus mosquitoes with Plasmodium vivax was compared with direct feeding of mosquitoes on gametocyte carriers. Volunteers participating in the study were symptomatic patients reporting to malaria clinics in western Thailand. Direct mosquito feeds were conducted on 285 P. vivax-infected individuals. Four methods of preparing blood for the membrane-feeding apparatus were evaluated. They included 1) replacement of patient plasma with sera from a P. vivax-naive donor (n = 276), 2) replacement of patient plasma with plasma from a P. vivax-naive donor (n = 83), 3) replacement of patient plasma with that individual's own plasma (n = 80), and 4) whole blood added directly to the feeder (n = 221). Criteria used to compare the different methods included 1) number of feeds infecting mosquitoes, 2) percent of mosquitoes with oocysts, and 3) mean number of oocysts per positive mosquito. For most parameters, the direct- feeding method was not significantly different from methods that replaced patient plasma with sera/plasma from a P. vivax-naive donor. However, direct feeding was more effective than use of whole blood or blood that was reconstituted with the patient's own plasma. These data suggest a possible role of transmission-blocking antibody. The implications towards development of a membrane-feeding assay for the evaluation of candidate transmission-blocking malaria vaccines is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695091

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  35 in total

1.  Infectivity of symptomatic and asymptomatic Plasmodium vivax infections to a Southeast Asian vector, Anopheles dirus.

Authors:  Kirakorn Kiattibutr; Wanlapa Roobsoong; Patchara Sriwichai; Teerawat Saeseu; Nattawan Rachaphaew; Chayanut Suansomjit; Sureemas Buates; Thomas Obadia; Ivo Mueller; Liwang Cui; Wang Nguitragool; Jetsumon Sattabongkot
Journal:  Int J Parasitol       Date:  2016-12-30       Impact factor: 3.981

Review 2.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 3.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Experimental infection of the neotropical malaria vector Anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon.

Authors:  Ajay R Bharti; Raul Chuquiyauri; Kimberly C Brouwer; Jeffrey Stancil; Jessica Lin; Alejandro Llanos-Cuentas; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2006-10       Impact factor: 2.345

5.  Consistent safety and infectivity in sporozoite challenge model of Plasmodium vivax in malaria-naive human volunteers.

Authors:  Sócrates Herrera; Yezid Solarte; Alejandro Jordán-Villegas; Juan Fernando Echavarría; Leonardo Rocha; Ricardo Palacios; Oscar Ramírez; Juan D Vélez; Judith E Epstein; Thomas L Richie; Myriam Arévalo-Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

Review 6.  Utilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study.

Authors:  Elizabeth B Brickley; Mamadou Coulibaly; Erin E Gabriel; Sara A Healy; Jen C C Hume; Issaka Sagara; Sekou F Traore; Ogobara Doumbo; Patrick E Duffy
Journal:  Vaccine       Date:  2016-10-24       Impact factor: 3.641

7.  Infection of mosquitoes from in vitro cultivated Plasmodium knowlesi H strain.

Authors:  Jennifer S Armistead; Roberto R Moraes Barros; Tyler J Gibson; Whitney A Kite; J Patrick Mershon; Lynn E Lambert; Sachy E Orr-Gonzalez; Juliana M Sá; John H Adams; Thomas E Wellems
Journal:  Int J Parasitol       Date:  2018-04-30       Impact factor: 3.981

8.  Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon.

Authors:  Shira R Abeles; Raul Chuquiyauri; Carlos Tong; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2013-03-11       Impact factor: 2.345

9.  LAP-like process as an immune mechanism downstream of IFN-γ in control of the human malaria Plasmodium vivax liver stage.

Authors:  Rachasak Boonhok; Nattawan Rachaphaew; Apisak Duangmanee; Pornpimol Chobson; Sittiporn Pattaradilokrat; Pongsak Utaisincharoen; Jetsumon Sattabongkot; Marisa Ponpuak
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

10.  Implementation of a novel PCR based method for detecting malaria parasites from naturally infected mosquitoes in Papua New Guinea.

Authors:  Arif U Hasan; Setsuo Suguri; Jetsumon Sattabongkot; Chigusa Fujimoto; Masao Amakawa; Masakazu Harada; Hiroshi Ohmae
Journal:  Malar J       Date:  2009-08-01       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.